Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2026-01-02 @ 12:46 AM
Study NCT ID:
NCT07090369
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-07-29
First Post:
2025-07-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer
Sponsor:
Peter MacCallum Cancer Centre, Australia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-15
First Submit QC Date:
None
Study First Post Date:
2025-07-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-24
Last Update Post Date:
2025-07-29
Last Update Post Date Type:
ACTUAL